Airway smooth muscle hyperplasia, driven at least partly by mediators such as transforming growth factor β (TGF-β) and HB-EGF, is considered to be a major contributor to airway remodelling, obstruction and hyper-responsiveness in asthma (17–19). This evidence concerns the gene HBEGF and asthma.